How Quality Improvement Interventions for Depression Affect Stigma Concerns Over Time

A Nine-Year Follow-Up Study

Published in: Psychiatric services, v. 60, no. 2, Feb. 2009, p. 258-261

Posted on RAND.org on January 01, 2009

by Ruth Klap, Lingqi Tang, Terry L. Schell, Naihua Duan, Kenneth B. Wells, Jeanne Miranda, Cathy D. Sherbourne

Read More

Access further information on this document at Psychiatric services

This article was published outside of RAND. The full text of the article can be found at the link above.

OBJECTIVE: This study examined the long-term impact on stigma concerns of two quality improvement (QI) interventions for depression in primary care. METHODS: Data were from a nine-year follow-up of 805 participants in Partners in Care, a group-level randomized trial comparing patients enrolled in interventions with enhanced resources for therapy (QI-therapy) (N=284) or medication management (QI-meds) (N=267) with those in usual care (N=254). Participants were asked about stigma in regard to friends, health insurance, and employers. RESULTS: Individuals in QI-therapy were significantly less likely than those in usual care and QI-meds to report concerns about friends learning about a history of depression (odds ratio [OR]=.66 and .65, respectively), and those in QI-meds were more likely than those in QI-therapy and usual care to have concerns about getting insurance (OR=1.42 and 1.68, respectively). CONCLUSIONS: Quality improvement programs for depression can raise or lower stigma concerns, depending on program design and resources for specific treatments.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.